Aspen Pharmacare Holdings Limited (JSE:APN)

Market Cap	44.78B
Revenue (ttm)	43.36B
Net Income (ttm)	-1.08B
Shares Out	444.21M
EPS (ttm)	-2.44
PE Ratio	n/a
Forward PE	8.16
Dividend	2.11 (2.07%)
Ex-Dividend Date	Oct 1, 2025

Volume	2,210,982
Average Volume	4,784,029
Open	10,151
Previous Close	10,200
Day's Range	9,925 - 10,329
52-Week Range	9,315 - 20,000
Beta	0.48
RSI	37.67
Earnings Date	Sep 3, 2025

About Aspen Pharmacare Holdings

Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and markets specialty and branded pharmaceutical products in Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia. It operates through Commercial Pharmaceuticals and Manufacturing segments. The company offers injectables for therapeutic areas, such as anaesthetics, anticoagulants, antithrombotic agents, analgesics, and hormone replacement medicines under the Arixtra, Diprivan, Fraxiparine, Marcaine, Sustanon, and Xylocaine brands; over-the-counte...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1850
• Employees: 9,350
• Stock Exchange: Johannesburg Stock Exchange
• Ticker Symbol: APN